The PCR single strand conformational polymorphism (PCR-SSCP) technique described to identify mutants of the SHV -lactamases was extended to identify an SHV-7 typelactamase. This was found in a strain of Klebsiella pneumoniae, the first recorded isolate in the UK to produce this type of enzyme. We also demonstrate that PCR-SSCP can be used to identify more than one SHV -lactamase gene in a single strain.
Introduction
Extended-spectrum cephalosporins have an important role in the therapy of serious Gram-negative sepsis. This role is threatened by the emergence and spread of extendedspectrum -lactamases (ESBLs) particularly those encoded by transmissible plasmids. 1 Two independent but genetically related families of ESBL have emerged: those derived from the TEM and SHV -lactamase genes. These have arisen by point mutations from progenitor genes that confer a penicillinase phenotype. The mutations are responsible for increasing the spectrum of activity to include extended-spectrum cephalosporins.
Identification of ESBLs has proved difficult: many subtypes result in only modest increases in MIC to extendedspectrum cephalosporins. This means their detection in the diagnostic laboratory is difficult when using either disc testing or break-point technologies. Identification methods have included the determination of biochemical and biophysical properties of the enzyme, including substrate profile analysis and determination of the isoelectric point of the protein. These methods require various degrees of protein purification and lack the discrimination to differentiate many enzymes. The only truly reliable method of identification is to determine the nucleotide sequence of the gene encoding the -lactamase. This, however, is costly and time-consuming and presents technical problems if the strain harbours two genes that differ by a small number of nucleotides since direct PCR sequencing may not be possible and differential cloning strategies may be necessary. PCR-SSCP (PCR single strand conformational polymorphism) can be employed to screen strains carrying genes that code for SHV -lactamases types 1-5. 2 This method relies on the observation that the migration of small singlestranded DNA molecules in non-denaturing gels is affected by conformational changes caused by point mutations. It thus permits detection of single base mutations without defining the nature of the alteration in the genetic code with respect to the base change or its position. We have expanded the recently described technique to identify the gene encoding SHV-7 3 and have also demonstrated that the technique can be successfully applied to strains that carry the genes encoding more than one SHV -lactamase.
Materials and methods

Bacterial strains
Three clinical isolates were used in this study. Klebsiella pneumoniae strain number 35440 was isolated from a wound swab taken from a patient nursed at the Leeds General Infirmary. K. pneumoniae strains 3391 and F1 were isolated from two patients in the intensive therapy unit of the Nadir Hospital, Tizi Ouzou, Algeria. As well as the clinical isolates, bacteria producing previously characterized SHV -lactamase were used as standard strains. 2 In addition, K. pneumoniae strain number 2669, isolated from a patient at St James' University Hospital, Leeds, pro-A 475 bp sequence of the SHV gene was PCR amplified using a pair of primers as described previously. 2 The PhastGel (Pharmacia Biotech Ltd, St Albans, UK) homogeneous 20 (containing 20% acrylamide) that was used for this study was run with PhastGel native buffer strips. Native buffer comprises 0.88 M L-alanine, 0.25 M Tris-HCl (pH 8.8) and the buffer strips are made of 3% agarose IEF.
Nucleotide sequence determination
The nucleotide sequence of PCR-generated amplimers were determined using a Sequenase 2.0 kit (United States Biochemicals, Cleveland, OH, USA) according to the manufacturer's instructions and using the same primers as for PCR amplification. Before nucleotide sequence determination, the amplimers were cleaned using a PCR Wizard (Promega, Madison, WI, USA). The nucletide sequences were determined on two independently generated amplimers to exclude the possibility of PCR artefacts.
Results and discussion
The SHV-7 -lactamase was reported in 1995, having been detected in a strain of E. coli isolated in the USA in 1993. 3 This enzyme has a pI of 7.6 and confers resistance to cefotaxime, ceftazidime, and aztreonam. In December 1994, an isolate of K. pneumoniae (strain number 35440) was isolated from a wound swab taken from a patient at the Leeds General Infirmary, Leeds, UK. This strain was found to be resistant to cefotaxime, ceftazidime, and aztreonam and produced an extended-spectrum -lactamase with a pI of 7.6. The MICs of these antibiotics are 32 mg/L, 128 mg/L, and 128 mg/L, respectively. These characteristics were all consistent with this enzyme being SHV-7. Using the previously described PCR-SSCP technique, the amplimer yielded a band pattern indistinguishable from that obtained with an amplimer generated from E. coli DH5-(pCLL3410) known to harbour SHV-7. 3 The Figure shows typical patterns obtained using this technique.
To confirm the identity of the -lactamase in the Leeds isolate the nucleotide sequence of the 475 bp amplimer was determined and was found to be indistinguishable from that of the published SHV-7 ESBL. 3 On the basis of the substrate profile, isoelectric point, PCR-SSCP, and limited nucleotide sequence, we conclude that K. pneumoniae strain number 35440 expresses an SHV-7 type -lactamase. We believe that this is the first report of this type of ESBL in the UK and the first outside the USA.
The mutations conferring extended spectrum activity in SHV-7 lie outside the region of DNA that is amplified but silent mutations within the amplimer permit its identification. It is interesting that our strain, expressing an SHV-7 PCR-SSCP pattern, substrate profile, and isoelectric point, and isolated in the UK, should carry the same silent mutations as those reported by Bradford and colleagues.
3 Any strains producing SHV-7 isolated in the future will require careful examination to determine whether all genes encoding SHV-7 have derived from a single evolutionary event or alternatively whether convergent evolution has occurred as seen with some TEM ESBLs.
5 Convergent evolution will be apparent from the production of a different SSCP-PCR profile.
Epidemiological investigations reveal that strains harbouring more than one -lactamase are reported with increasing frequency. 6 Almost all strains of K. pneumoniae express SHV-1 since the gene is carried on the bacterial chromosome.
1 K. pneumoniae (strains 3391 and F1) isolated from two patients in the intensive therapy unit of the Nadir Hospital, Tizi Ouzou, Algeria, represent such strains. Isoelectric focusing suggests that these strains produce both SHV-1 and SHV-5. When these isolates are subjected to PCR-SSCP analysis they yield the expected pattern: the bands of SHV-5 are superimposed on the pattern of that of SHV-1 (Figure) . By extrapolation, we expect other combinations of SHV genes to be distinguishable. Given the widespread occurrence of the narrowspectrum SHV-1 -lactamase, this result indicates that PCR-SSCP remains a valuable tool for the rapid screening and identification of ESBL genes, even if more than one gene is carried by a strain. Its use circumvents the need for a full nucleotide sequence determination on every isolate expressing an ESBL phenotype. It also overcomes the problem associated with oligonucleotide probes -that only previously identified mutations may be detected. Its use to characterize two -lactamase genes in a single strain also avoids the problems associated with separating genes prior to sequence determination.
